p53 expression and resistance against paclitaxel in patients with metastatic breast cancer
2003 · Journal of Cancer Research and Clinical Oncology · 45 citations
https://doi.org/10.1007/s00432-003-0430-1
A
Anja Victor
Merck (Germany)(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
2.3K
Citations
24
h-index
37
i10-index
Anja Victor is an academic researcher from Merck (Germany). The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Statistical Methods in Clinical Trials. The author has an h-index of 24, co-authored 68 publications.
Papers by this author
worksRole of the progesterone receptor for paclitaxel resistance in primary breast cancer
2007 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/sj.bjc.6603538
TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial
2025 · Journal for ImmunoTherapy of Cancer · 6 citations
https://doi.org/10.1136/jitc-2024-010584
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat